Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica®, Venclexta™, and Empliciti™ — and a pipeline containing multiple promising new molecules that are being studied in nearly 200 clinical trials in 19 different types of cancer.

AbbVie is expanding its oncology hub on the West Coast, with three sites in the San Francisco Bay Area (Redwood City, South San Francisco, and Sunnyvale) focused on the discovery and development of novel oncology therapies. More than 1,000 AbbVie scientists, clinicians, and product developers with strong entrepreneurial roots work across these three sites. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. This position will be based at Stemcentrx, AbbVie's South San Francisco, CA location.

Description

MSAT Specialist will be part of a small GMP Manufacturing team working in collaboration with Process Sciences and Quality to execute GMP production runs to supply the company's clinical Antibody Drug Conjugate (ADC) pipeline. They will perform on-the-floor operations within the biologics production facility to produce clinical material for human trials using state of the art single-use disposable technology. They will support activities related to buffer prep, maintenance, supply planning, shipping/receiving, and quality testing with additional opportunities to lead technology projects, coordinate processes and participate in tech transfer.